The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Receptor tyrosine kinases (RTKs) like ErbB and FGFR are implicated in breast cancer.
• The role of Ret receptor tyrosine kinase in breast tumor biology remains largely unexplored.

Purpose of the Study:

• To investigate the contribution of Ret receptor tyrosine kinase to breast tumor biology.
• To determine if Ret signaling is functional in breast cancer cells and interacts with estrogen receptor (ER) pathways.

Main Methods:

• Ret expression analysis in primary breast tumors and cell lines.
• Functional assays using ERalpha-positive MCF7 and T47D cells treated with glial-derived neurotrophic factor (GDNF).
• Assessment of Ret signaling activation, anchorage-independent proliferation, and interaction with estrogen-driven proliferation.

Main Results:

• Ret was expressed in primary breast tumors and cell lines.
• Glial-derived neurotrophic factor activated Ret signaling, increasing proliferation in ERalpha-positive breast cancer cells.
• Estrogens induced Ret expression, and Ret signaling enhanced estrogen-driven proliferation, indicating a functional interaction between Ret and ER pathways.
• Higher Ret levels were observed in ERalpha-positive primary breast tumors.

Conclusions:

• Ret is a novel proliferative pathway in breast cancer that functionally interacts with ER signaling.
• Ret expression in primary tumors suggests its potential as a new therapeutic target for breast cancer, particularly in ERalpha-positive subtypes.